BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9192263)

  • 1. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS.
    Swillen A; Devriendt K; Legius E; Eyskens B; Dumoulin M; Gewillig M; Fryns JP
    J Med Genet; 1997 Jun; 34(6):453-8. PubMed ID: 9192263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
    Oh AK; Workman LA; Wong GB
    Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome).
    Antshel KM; Conchelos J; Lanzetta G; Fremont W; Kates WR
    Psychiatry Res; 2005 Apr; 138(3):235-45. PubMed ID: 15854791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome.
    Gothelf D; Presburger G; Levy D; Nahmani A; Burg M; Berant M; Blieden LC; Finkelstein Y; Frisch A; Apter A; Weizman A
    Am J Med Genet B Neuropsychiatr Genet; 2004 Apr; 126B(1):116-21. PubMed ID: 15048660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience.
    Vantrappen G; Rommel N; Devriendt K; Cremers CW; Feenstra L; Fryns JP
    Acta Otorhinolaryngol Belg; 2001; 55(1):43-8. PubMed ID: 11256191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence.
    McDonald-McGinn DM; Driscoll DA; Emanuel BS; Goldmuntz E; Clark BJ; Solot C; Cohen M; Schultz P; LaRossa D; Randall P; Zackai EH
    Pediatrics; 1997 May; 99(5):E9. PubMed ID: 9113966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CATCH 22.
    Hall JG
    J Med Genet; 1993 Oct; 30(10):801-2. PubMed ID: 8230153
    [No Abstract]   [Full Text] [Related]  

  • 8. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective.
    Cable BB; Mair EA
    Ear Nose Throat J; 2003 Jan; 82(1):56-60. PubMed ID: 12610907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
    Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
    J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
    Swillen A; Devriendt K; Legius E; Prinzie P; Vogels A; Ghesquière P; Fryns JP
    Genet Couns; 1999; 10(1):79-88. PubMed ID: 10191433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Syndromes 3. Velo-cardio-facial (VCF/Shprintzen) syndrome].
    Beemer FA
    Ned Tijdschr Tandheelkd; 1998 Aug; 105(8):287-8. PubMed ID: 11928434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients.
    Ford LC; Sulprizio SL; Rasgon BM
    Laryngoscope; 2000 Mar; 110(3 Pt 1):362-7. PubMed ID: 10718420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 22q11 deletion and other chromosome aberrations in cases with cleft palate, congenital heart defects and/or mental disability. A survey based on the Danish Facial Cleft Register.
    Brøndum-Nielsen K; Christensen K
    Clin Genet; 1996 Sep; 50(3):116-20. PubMed ID: 8946108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Velocardiofacial syndrome in a mother and daughter: variability of the clinical phenotype.
    Holder SE; Winter RM; Kamath S; Scambler PJ
    J Med Genet; 1993 Oct; 30(10):825-7. PubMed ID: 8230158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometry of the head of the caudate nucleus in patients with velocardiofacial syndrome (del 22q11.2).
    Sugama S; Bingham PM; Wang PP; Moss EM; Kobayashi H; Eto Y
    Acta Paediatr; 2000 May; 89(5):546-9. PubMed ID: 10852189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.
    Niklasson L; Rasmussen P; Oskarsdóttir S; Gillberg C
    Dev Med Child Neurol; 2002 Jan; 44(1):44-50. PubMed ID: 11811651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric inpatients and chromosome deletions within 22q11.2.
    Sugama S; Namihira T; Matsuoka R; Taira N; Eto Y; Maekawa K
    J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):803-6. PubMed ID: 10567504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-academic and early academic achievement in children with velocardiofacial syndrome (del22q11.2) of borderline or normal intelligence.
    De Smedt B; Swillen A; Ghesquière P; Devriendt K; Fryns JP
    Genet Couns; 2003; 14(1):15-29. PubMed ID: 12725586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability?
    Swillen A; Vandeputte L; Cracco J; Maes B; Ghesquière P; Devriendt K; Fryns JP
    Child Neuropsychol; 1999 Dec; 5(4):230-41. PubMed ID: 10925707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.
    Goldmuntz E; Driscoll D; Budarf ML; Zackai EH; McDonald-McGinn DM; Biegel JA; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):807-12. PubMed ID: 7901419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.